期刊文献+

sHLA-A*0201-抗原肽四聚体的构建与功能检测 被引量:1

The preparation and functional test for HLA-A*0201-peptide tetramer
下载PDF
导出
摘要 目的:构建有功能的sHLA-A*0201-抗原肽四聚体,建立一套HLAⅠ类分子/抗原肽的四聚体制备技术。方法:利用基因工程及体外折叠技术构建sHLA-A*0201-LMP2A426-434复合物分子,并在BirA酶的作用下生物素化,与荧光标记的亲和素衍生物以分子数4∶1结合而形成HLA-A*0201-LMP2A426-434四聚体。获得的四聚体对长期混合淋巴细胞培养中增殖的抗原特异性CTL进行检测,同时用细胞毒实验验证。结果:荧光标记的亲和素与生物素化的HLA-A*0201-抗原肽复合物分子正确结合,制备的四聚体能够与长期混合淋巴细胞培养出的特异性T细胞结合。结论:从结构与功能上证实成功地获得有功能的HLA-A*0201-抗原肽复合物四聚体。为进一步研究T细胞识别机制与功能奠定了基础,也为过程复杂的HLA-抗原肽四聚体制备提供了可行的免疫学监控方法。 Objective:To prepare a sHLA-A2/peptide tetramer and set up the protocols which can be used for preparation of other types of sHLA class Ⅰ molecules with the corresponding peptide. Methods: sHLA-A2/LMP2A426-434 tetramer was prepared by mixing the biotinylated peptide-HLA complex with phycoerythrin(PE) labeled avidin at a molar ratio of 4: 1. We apply our prepared sHLA-A2/LMP2A426-434 tetramer to stain the cells after long term mixed lymphocytes culture. Results:The results indicated sHLA-A2/ LMP2A426-434, tetramer has been correctly constructed in structure and the tetramer was able to discriminate the frequencies of specific CTL induced by HLA-A2/LMP2A426-434. Conclusion:We have successfully constructed the HLA-A*0201/LMP2A426-434, tetramer and lay the foundation for further study of T cell recognition.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2006年第3期244-247,251,共5页 Chinese Journal of Immunology
基金 国家自然科学基金(30271201) 科技部973计划(2001CB510008)资助
关键词 HLA-A*0201-抗原肽复合物 生物素化 BirA HLA-A*0201-抗原肽四聚体 抗原特异性CTL HLA-A*0201-peptide complex Biotinylate BirA enzyme HLA-A*0201-peptide tetramer Peptide-specifie CTL
  • 相关文献

参考文献10

  • 1Altman J D,Moss P A,Goulder P J R et al.Phenotypic analysis of antigen-specific T lymphocytes[J].Science,1996;274(5284):94-96.
  • 2McMichael A J,Callaghan C A.A new look at T cells[J].J Exp Med,1998;187(9):1367-1371.
  • 3陈浩,翁秀芳,吴雄文,梁智辉,韩军艳,黄亚非,龚非力.人β_2m基因的克隆及表达[J].华中科技大学学报(医学版),2004,33(1):1-4. 被引量:7
  • 4Maziarz R T,Fraser J,Srominger J L et al.The human HLA-specific monoclonal antibody W6/32 recognizes a discontinuous epitope within the alpha 2 domain of murine H-2Db[J].Immunogenetics,1986;24:206-208.
  • 5Garboczi D N,Hung D T,Wiley D C et al.HLA-A2-peptide complexes:refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides[J].Proc Natl Acad Sci USA,1992;89(8):3429-3433.
  • 6Parker K C,Silver M L,Wiley D C.An HLA-A2/β2m/peptide complex assembled from subunits expressed separately in E.coli[J].Mol Immunol,1992;29(3):371-378.
  • 7Ocallaghan C A,Byford M F,Wyer J R et al.BirA enzyme:production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation[J].Anall Biochem,1999;266(1):9-15.
  • 8Tham E L,Jensen P L,Mescher M F.Activation of antigen-specific T cells by artificial cell construcs having immobilized multimeric peptide-class Ⅰ complexes and recombinant B7-Fc protein[J].J Immunonol Methods,2001;249(1-2):111-119.
  • 9Hosken NA,Bevan M J.Defective presentation of endogenous antigen by a cell line expressing class Ⅰ molecules[J].Science,1990;248:367-370.
  • 10房崇芸,吴雄文,韩军艳,刘敏,梁智辉,龚非力.长期混合淋巴细胞培养-细胞毒实验模型的建立[J].中华器官移植杂志,2001,22(5):277-279. 被引量:6

二级参考文献4

  • 1熊平,扬颖,龚非力.一种新的HLA─Ⅱ类基因分型方法——PCR/SSP技术的建立[J].免疫学杂志,1996,12(4):258-261. 被引量:41
  • 2Garboczi D N,Hung D T,Wiley D C et al.HLA-A2-peptide complexes:refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides[].Proceedings of the National Academy of Sciences of the United States of America.1992
  • 3Bjorkman P J,Strominger J L,Wiley D C.Crystallization and X-ray diffraction studies on the histocompati-bility antigens HLA-A2 and HLA-A28 from human cell membranes[].Journal of Molecular Biology.1985
  • 4Vitiello A,Potter T A,Sherman L A.The role of beta 2-microglobulin in peptide binding by class I molecules[].Science.1990

共引文献11

同被引文献8

  • 1杨敬宁,吴雄文,梁智辉,韩军艳,黄亚非,龚非力.可溶性HLA-G1抗原肽复合物的体外折叠及其功能研究[J].细胞与分子免疫学杂志,2005,21(3):265-268. 被引量:4
  • 2FAHMY T M, BIELER J G, SCHNECK J P. Probing T cell membrane organization using dimeric MHC-Ig complexes[J]. J Immunol Methods, 2002, 268(1): 93-106.
  • 3DAL PORTO J, JOHANSEN T E, CATIPOVIC B, et al. A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations [J]. Proc Natl Acad Sci USA, 1993,90(14):6671-6675.
  • 4CAREY B, DELAY M, STRASSER J E, et al. A soluble divalent class I MHC/IgG1 fusion protein activates CD8^+ T cells in vivo[J]. Clin Immunol, 2005, 116(1): 65-76.
  • 5WENG X F, ZHONG M H, LIANG Z H, et al. Peptide-dependent inhibition of alloreactive T-cell response by soluble divalent HLA-A2/IgG molecule in vitro [J].Transplantaion, 2007, 84(10) : 1298-1306.
  • 6SHIELDS M J, RIBAUDO R K. Mapping of the monoelonal antibody W6/32: sensitivity to the amino terminus of beta2- microglobulin[J]. Tissue Antigens,1998,51(5) : 567-570.
  • 7GESSNER J E, HEIKEN H, TAMM A, et al. The IgG Fc receptor family[J].Ann Hematol, 1998,76 (66) ; 231-248.
  • 8STORKUS W J, ZEHIII H J, SALTER R D, et al. Indentification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution[J]. J Biol Chem,1993, 268(10) :7019-7027.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部